Woodley Farra Manion Portfolio Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Woodley Farra Manion Portfolio Management's AZN Position: Q2 2026 in Review
Woodley Farra Manion Portfolio Management increased its AstraZeneca (AZN) stake by 0.14% in Q2 2026, buying an estimated $95.5K and bringing the position to 369,477 shares worth $70.1M. The position accounts for 3.37% of the portfolio, ranked #8.
Woodley Farra Manion Portfolio Management first reported a position in AZN in Q3 2023 and has held it in 10 quarters since. The position peaked at $72.8M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Woodley Farra Manion Portfolio Management held 369,477 shares of AstraZeneca worth $70.1M as of Q2 2026.
- Woodley Farra Manion Portfolio Management bought 508 AstraZeneca shares in Q2 2026, an estimated $95.5K.
- AstraZeneca made up 3.37% of Woodley Farra Manion Portfolio Management's portfolio in Q2 2026, its #8 holding.
- Woodley Farra Manion Portfolio Management first reported a position in AstraZeneca in Q3 2023 and has held it in 10 quarters since.
- Woodley Farra Manion Portfolio Management's AstraZeneca position peaked at $72.8M in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Woodley Farra Manion Portfolio Management's 13F filing for Q2 2026, filed 10 Aug 2026.